Think Growth. Think IPOX®.
We offer specialized solutions for investors seeking exposure to New Listings - a proxy for economic growth and innovation.
Upcoming Global IPOs
The IPOX® Newsletters
IPO News
London's IPO market shows mixed signals with French streaming firm Canal+ planning a €5-6 billion listing, while facing challenges with Shein's delayed approval over supply chain concerns. In Asia, Orion Breweries prepares for a $200 million Tokyo listing, Foshan Haitian seeks a HK$1.5 billion Hong Kong dual listing, and Kioxia completed an $800 million IPO, though at a valuation significantly below its 2018 level.
Recent IPO announcements reflect strong global market activity across diverse sectors. Notable listings include Holcim's $30 billion North American spin-off, Seven & i's $6.6 billion 7-Eleven USA IPO, and ServiceTitan's $5.16 billion tech listing in the U.S. The MENA region sees healthcare and retail offerings from Almoosa Health and Nice One, while Asia-Pacific activity includes Kioxia's $727 million Tokyo listing and Mao Geping's $270 million Hong Kong debut.
Global companies are preparing IPOs amid varied market conditions. In the U.S., ServiceTitan and CoreWeave plan significant offerings despite financial pressures. European firms like Apotea, Thyssenkrupp's Marine Systems, Odido, and Cirsa are set for listings. In Asia-Pacific, Insta360 and Mr DIY's Indonesian arm aim to go public. MENA's Talabat plans the UAE's largest IPO. Biotech firms Odyssey and Aktis proceed despite sector uncertainties, and Australia's Anteris files for a U.S. IPO.
IPOX® in the News
IPOX® CEO Josef Schuster sat down with Chuck Jaffe on the Money Life with Chuck Jaffe podcast to discuss the state of the IPO market, its strong performance amid market highs, and the factors driving its momentum. Schuster highlighted the role of low interest rates, robust earnings, and the rise of sectors like AI and industrials in fueling IPO growth.
Josef Schuster, founder and CEO of IPOX Schuster LLC, was recently featured in Reuters, offering his perspective on the upcoming IPO of ServiceTitan, which aims for a valuation of up to $5.16 billion.
IPOX® CEO Josef Schuster shared insights with Bloomberg on the renewed optimism in Canada’s IPO market, highlighted by Groupe Dynamite Inc.’s C$300 million debut. Schuster emphasized the IPOX® Canada Opportunities Index's adaptability, which has delivered a strong 36% return this year, outperforming the S&P/TSX Composite Index. The index reflects growing investor confidence and emerging opportunities as Canada’s equity markets show signs of recovery.
IPOX® CEO Josef Schuster, portfolio manager and subadvisor to the Rakuten Global IPO Stock Fund, was featured in Japan’s Nikkei Newspaper (日本経済新聞), talking about Reddit’s impressive post-IPO growth, underscoring IPOX's focus on identifying high-potential companies in the evolving global IPO landscape.
IPOX® Research Analyst Dr. Lukas Muehlbauer commented on Septerna's upsized U.S. IPO as the Goldman Sachs-backed drug developer targets a valuation of $743.1 million. Septerna, originally planning to offer 10.9 million shares within a $15-$17 range, has now increased its offering to 15.3 million shares, pricing them at $18 each, to raise approximately $275 million. This move reflects positive investor sentiment for biotech IPOs, which have seen strong performances in the U.S. market this fall.